Literature DB >> 21336514

Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy.

David Yu Greenblatt1, Kaitlyn J Kelly, Victoria Rajamanickam, Yin Wan, Todd Hanson, Robert Rettammel, Emily R Winslow, Clifford S Cho, Sharon M Weber.   

Abstract

BACKGROUND: Pancreaticoduodenectomy (PD) has long been associated with high rates of morbidity and mortality. The objective of this study was to identify preoperative risk factors for serious complications and mortality after PD and to construct a prediction tool to facilitate risk stratification prior to surgery.
MATERIALS AND METHODS: Patients who underwent elective PD from 2005 to 2009 were identified from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database. Multivariate logistic regression identified predictors of 30-day serious complications and mortality. A prediction tool was created and validated in a sample of 1254 patients.
RESULTS: Of 4945 patients who underwent PD, 1342 (27.1%) suffered a serious complication and 127 (2.6%) died within 30 days. The most frequent complications were sepsis (15.3%), surgical site infection (13.1%), and respiratory complications (9.5%). After adjusting for potential confounders, the significant predictors of morbidity included older age, male gender, overweight and obesity, dependent functional status, chronic obstructive pulmonary disease (COPD), steroid use, bleeding disorder, leukocytosis, elevated serum creatinine, and hypoalbuminemia. Significant predictors of 30-day mortality included COPD, hypertension, neoadjuvant radiation therapy, elevated serum creatinine, and hypoalbuminemia. Multivariable models were used to construct a preoperative risk stratification tool.
CONCLUSIONS: Preoperative factors are associated with perioperative outcomes after PD. The prediction tool estimates the probability of early morbidity and mortality for patients undergoing PD. The tool may be used to provide information for patient counseling during the informed consent process and to identify high-risk patients for the purpose of tailoring perioperative care.

Entities:  

Mesh:

Year:  2011        PMID: 21336514     DOI: 10.1245/s10434-011-1594-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  87 in total

1.  A New Feasible Technique for Polytetrafluoroethylene Suture Buttress-Reinforced Pancreaticojejunostomy (PBRP): Mechanical Analysis and a Prospective, Randomized Controlled Trial.

Authors:  Xinxin Shao; Yibin Xie; Quan Xu; Anqiang Sun; Zhenze Wang; Yantao Tian
Journal:  J Gastrointest Surg       Date:  2018-12-03       Impact factor: 3.452

2.  Risk of morbidity and mortality following hepato-pancreato-biliary surgery.

Authors:  Peter J Kneuertz; Henry A Pitt; Karl Y Bilimoria; Jill P Smiley; Mark E Cohen; Clifford Y Ko; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2012-07-04       Impact factor: 3.452

3.  Comparison of observed to predicted outcomes using the ACS NSQIP risk calculator in patients undergoing pancreaticoduodenectomy.

Authors:  Harveshp D Mogal; Nora Fino; Clancy Clark; Perry Shen
Journal:  J Surg Oncol       Date:  2016-05-04       Impact factor: 3.454

4.  A root-cause analysis of mortality following major pancreatectomy.

Authors:  Charles Mahlon Vollmer; Norberto Sanchez; Stephen Gondek; John McAuliffe; Tara S Kent; John D Christein; Mark P Callery
Journal:  J Gastrointest Surg       Date:  2011-11-08       Impact factor: 3.452

5.  Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classification.

Authors:  Ching-Wei D Tzeng; Matthew H G Katz; Jason B Fleming; Jeffrey E Lee; Peter W T Pisters; Holly M Holmes; Gauri R Varadhachary; Robert A Wolff; James L Abbruzzese; Jean-Nicolas Vauthey; Thomas A Aloia
Journal:  J Gastrointest Surg       Date:  2013-10-16       Impact factor: 3.452

6.  Trends and risk factors for transfusion in hepatopancreatobiliary surgery.

Authors:  Donald J Lucas; Katherine I Schexneider; Matthew Weiss; Christopher L Wolfgang; Steven M Frank; Kenzo Hirose; Nita Ahuja; Martin Makary; John L Cameron; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2013-12-10       Impact factor: 3.452

7.  Analysis of risk factors for hemorrhage and related outcome after pancreatoduodenectomy in an intermediate-volume center.

Authors:  Fabio Uggeri; Luca Nespoli; Marta Sandini; Anita Andreano; Luca Degrate; Fabrizio Romano; Laura Antolini; Luca Gianotti
Journal:  Updates Surg       Date:  2019-08-02

8.  Hospital-based, acute care encounters after radiofrequency ablation of hepatic tumours.

Authors:  Rebecca M Tuttle; Justin P Fox; James R Ouellette; Minia Hellan
Journal:  HPB (Oxford)       Date:  2014-01-28       Impact factor: 3.647

9.  Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer.

Authors:  Eric A Mellon; Tobin J Strom; Sarah E Hoffe; Jessica M Frakes; Gregory M Springett; Pamela J Hodul; Mokenge P Malafa; Michael D Chuong; Ravi Shridhar
Journal:  J Gastrointest Oncol       Date:  2016-08

10.  The effect of resident participation on short-term outcomes after orthopaedic surgery.

Authors:  Andrew J Pugely; Yubo Gao; Christopher T Martin; John J Callagh; Stuart L Weinstein; J Lawrence Marsh
Journal:  Clin Orthop Relat Res       Date:  2014-07       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.